Pharmacokinetic Interaction Study of Dapoxetine 30mg and Mirodenafil 100mg

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

November 30, 2014

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions

Drug Interaction Potentiation

Interventions

DRUG

Dapoxetine 30mg

Tablet, Orally administered

DRUG

Mirodenafil 100mg

Table, Orally administered

All Listed Sponsors

lead

SK Chemicals Co., Ltd.

INDUSTRY

NCT02485041 - Pharmacokinetic Interaction Study of Dapoxetine 30mg and Mirodenafil 100mg | Biotech Hunter | Biotech Hunter